LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.17783
 29.19 27.76 26 1863 0.0140 -0.0107
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 29.19 27.76 1236 1863 0.6634 0.8692
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 29.19 27.76 20 1863 0.0107 -0.0526
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 29.19 27.76 1290 1863 0.6924 0.8824
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 30.90 27.76 16 2032 0.0079 -0.0851
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 30.90 27.76 1305 2032 0.6421 0.8620
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 30.90 27.76 25 2032 0.0123 -0.0168
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 30.90 27.76 1384 2032 0.6810 0.8797
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 32.60 27.76 32 2235 0.0143 0.0227
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 32.60 27.76 1370 2235 0.6127 0.8511
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 32.60 27.76 26 2235 0.0116 -0.0103
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 32.60 27.76 1439 2235 0.6436 0.8655
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 34.30 27.76 31 2449 0.0127 0.0172
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 34.30 27.76 1456 2449 0.5943 0.8453
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 34.30 27.76 22 2449 0.0090 -0.0353
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 34.30 27.76 1524 2449 0.6221 0.8584
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 36.01 27.76 40 2662 0.0150 0.0571
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 36.01 27.76 1496 2662 0.5618 0.8323
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 36.01 27.76 39 2662 0.0146 0.0530
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 36.01 27.76 1611 2662 0.6050 0.8530
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 37.71 27.76 45 2877 0.0156 0.0748
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 37.71 27.76 1573 2877 0.5466 0.8275
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 37.71 27.76 45 2877 0.0156 0.0748
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 37.71 27.76 1659 2877 0.5765 0.8421
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 39.41 27.76 52 3105 0.0167 0.0966
MN20160318_Q01
E22